Skip to main content
Clinical Trials/CTRI/2022/11/047707
CTRI/2022/11/047707Not yet recruitingNot Applicable

Effect Of MgSO4 Nebulization On Incidence Of Post Op Sore Throat

Government of Gujarat1 site in 1 country60 target enrollmentStarted: November 28, 2022Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
Pre op nebulization with MgSO4 , Less Time for laryngoscopy, Short Surgery time helpful in prevention of postoperative sore throat.

Study Overview

Brief Summary

Sore throat related to orotracheal tube might be a consequence of localized trauma, leading to aseptic inflammation of the pharyngeal mucosa. Magnesium being an NMDA receptor antagonist, has a role in preventing NMDA receptor-mediated nociception and inflammation and thereby POST. Nebulization with magnesium sulphate helpful in reduction of severity of postoperative sore throat.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • ASA I & II , elective surgery less than 2 hours.

Exclusion Criteria

  • ASA III, IV , V.
  • , Negative consent, comorbidity patients, pre-existing sore throat.

Outcomes

Primary Outcomes

Pre op nebulization with MgSO4 , Less Time for laryngoscopy, Short Surgery time helpful in prevention of postoperative sore throat.

Time Frame: Continues monitoring of vitals and ask about sore throat for 24 hours after Extubation.eg.0 hours, 2 hours, 4 hours, 6 hours, 8 hours, 24 hours.

Secondary Outcomes

  • Sore throat grading applied (Grade 0-3)(Measured every 2 hourly upto 8 hours and than at 24 hour.)

Investigators

Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials